GenVec (GNVC) Reports In-Line Q1 Loss of $0.06
More News related to GNVC
- GenVec (GNVC) Reports In-line Results for Q3
- GenVec Reports Third Quarter 2009 Financial Results
- SAIC-Frederick Signs $22M Contract with GenVec (GNVC) for Flu and HIV Vaccine Development
- GenVec Signs New Contract to Support HIV and Influenza Vaccine Development
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
More News related to Earnings
- Regent Communications (RGCI) Receives Delisting Notification From NASDAQ
- Emclaire Financial (EMCF) to Withdraw $20M Common Offerin; Cites Unfavorable Market Conditions
- Swine Flu Cases Decline to Lowest Level in 2+ Months
- Tri-Valley Corp. (TIV) Will Stay on NYSE AMEX, Deficiency Resolved
- Phoenix Footwear (PXG) Enters into $4.5M Secured Revolving Credit Facility
GenVec, Inc. (Nasdaq: GNVC) reports Q1 loss of $0.06, in-line with the analyst estimate of ($0.06). Revenue for the quarter was $3.8 million, versus the consensus of $3.40 million.
Related Categories
EarningsStocks Mentioned
+0.02Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
